Loading…
Kura Oncology, Inc. is projected to rise to $11.42 by 2027, a +27% move from its current price of $9.01. KURA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $8.74 | $9.01 | $9.29 | +0.01% |
| Aug 3 | $8.63 | $9.01 | $9.41 | +0.02% |
| Aug 4 | $8.54 | $9.01 | $9.51 | +0.03% |
| Aug 5 | $8.47 | $9.01 | $9.59 | +0.04% |
| Aug 6 | $8.41 | $9.01 | $9.66 | +0.05% |
| Aug 7 | $8.36 | $9.02 | $9.72 | +0.06% |
| Aug 8 | $8.31 | $9.02 | $9.78 | +0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.31 | $9.02 | $9.78 | +0.07% |
| Week 2 | $8.04 | $9.02 | $10.13 | +0.14% |
| Week 3 | $7.84 | $9.03 | $10.40 | +0.21% |
| Week 4 | $7.67 | $9.04 | $10.64 | +0.28% |
| Week 5 | $7.53 | $9.04 | $10.86 | +0.35% |
| Week 6 | $7.40 | $9.05 | $11.05 | +0.42% |
| Week 7 | $7.29 | $9.05 | $11.24 | +0.49% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of cancer. Its first commercial product KOMZIFTI (ziftomenib) is a potent, selective, reversible and oral small molecule menin inhibitor.
The company’s pipeline also includes Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications, and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Kura Oncology, Inc. (KURA) is trading with a current price of $9.31 and a market capitalization of $826.49M. It is ranked 2563 by market size among listed companies. The latest price outlook shows a mixed to bullish path over the coming years, with near-term neutral pricing and longer-term upside potential.
By 2026 the average forecast price is $9.31 with a 0% ROI, and from 2027 onward the forecast envisions a rising path to $16.72 by 2030 and $83.07 by 2050, with substantial positive ROIs along the way.
A major floor 24.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.9% away) — a key level to hold.
The nearest ceiling, 34.5% above — a clean break opens room to run.
A major ceiling 46.6% above — clearing it would confirm fresh momentum.
Key KURA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KURA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.34 | Sell | $9.38 | Sell |
| MA 10 | $9.97 | Sell | $9.81 | Sell |
| MA 20 | $10.68 | Sell | $10.19 | Sell |
| MA 50 | $10.20 | Sell | $10.14 | Sell |
| MA 100 | $9.56 | Sell | $9.81 | Sell |
| MA 200 | $9.64 | Sell | $9.54 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 34.28 | Neutral |
| Stoch RSI (14) | 12.93 | Buy |
| CCI (20) | -151.59 | Sell |
| Williams %R (14) | -96.67 | Info |
| MACD (12,26,9) | -0.28 | Sell |
| ROC (12) | -20.48 | Sell |
| Bollinger %B (20,2) | 0.05 | Neutral |
| Stochastic %K (14) | 3.33 | Buy |
| TRIX (15) | 0.00 | Buy |
| Awesome (5,34) | -1.17 | Sell |
| Ultimate (7,14,28) | 22.77 | Buy |
| Momentum (10) | -1.85 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 8.76 | Buy |
| ADX (14) | 20.35 | Sell |
| ATR (14) | 0.30 | Info |
Near-term sentiment is NEUTRAL. The RSI14 is 40, indicating a neutral momentum. The 50-day simple moving average is $10.20 and the 200-day simple moving average is $9.66, providing a near-term support near the price level and a modest cushion above longer-term averages.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.40 | $9.01 | $11.66 | 0% | Neutral | |
| $9.00 | $11.42 | $15.39 | +27% | Bullish | |
| $11.27 | $14.77 | $20.75 | +64% | Bullish | |
| $10.93 | $14.73 | $21.37 | +63% | Bullish | |
| $11.18 | $15.42 | $23.00 | +71% | Bullish | |
| $12.32 | $17.37 | $26.51 | +93% | Bullish | |
| $11.64 | $16.75 | $26.11 | +86% | Bullish | |
| $12.86 | $18.85 | $29.95 | +109% | Bullish | |
| $15.33 | $22.88 | $36.99 | +154% | Bullish | |
| $16.77 | $25.47 | $41.86 | +183% | Bullish | |
| $19.82 | $32.58 | $57.29 | +262% | Bullish | |
| $37.53 | $70.91 | $137.47 | +687% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $7.40 | $9.01 | $10.73 | +0.00% |
| September 2026 | $7.36 | $8.75 | $10.71 | -2.91% |
| October 2026 | $7.60 | $9.09 | $11.26 | +3.94% |
| November 2026 | $7.75 | $9.34 | $11.68 | +2.70% |
| December 2026 | $7.63 | $9.24 | $11.66 | -1.01% |
Click any year to see its month-by-month KURA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, KURA is projected to trade between $7.40 and $11.66, averaging $9.01 — a potential gain of 0% from today's $9.01. Price action looks broadly range-bound.
Kura Oncology, Inc.'s 2027 outlook centres on $11.42, within a $9.00 to $15.39 range. That is up +27% on the projected 2026 average. That marks a +27% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, KURA could reach as high as $20.75, with a base case around $14.77 and support toward $11.27 — roughly +64% from $9.01. Momentum favours further upside here.
Expect KURA to range from $10.93 to $21.37 through 2029. The $14.73 average target implies a +63% move from current prices. That is 0% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
The KURA price prediction for 2030 points to an average of $15.42 (low $11.18, high $23.00) — a potential gain of +71% on today's $9.01. Momentum favours further upside here.
In 2031, KURA is projected to trade between $12.32 and $26.51, averaging $17.37 — a potential gain of +93% from today's $9.01. That is up +13% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Kura Oncology, Inc.'s 2032 outlook centres on $16.75, within a $11.64 to $26.11 range. That is -4% versus the projected 2031 average. That marks a +86% change versus current levels. Momentum favours further upside here.
By 2033, KURA could reach as high as $29.95, with a base case around $18.85 and support toward $12.86 — roughly +109% from $9.01. Buyers look set to stay in control over this stretch.
Expect KURA to range from $15.33 to $36.99 through 2034. The $22.88 average target implies a +154% move from current prices. That is up +21% on the projected 2033 average. Momentum favours further upside here.
The KURA price prediction for 2035 points to an average of $25.47 (low $16.77, high $41.86) — a potential gain of +183% on today's $9.01. Buyers look set to stay in control over this stretch.
In 2040, KURA is projected to trade between $19.82 and $57.29, averaging $32.58 — a potential gain of +262% from today's $9.01. That is up +28% on the projected 2035 average. Momentum favours further upside here.
Kura Oncology, Inc.'s 2050 outlook centres on $70.91, within a $37.53 to $137.47 range. That is up +118% on the projected 2040 average. That marks a +687% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in KURA today (≈ 110.987791 KURA) could be worth
$7,869.94
+$6,869.94 (+687%) by 2050 · US Dollar
Based on the average projected KURA price of $70.91 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KURAwould be worth at today's price.
$1,000 invested in KURA on Jul 31, 2025 (≈ 165.289251 KURA) would be worth
$1,489.26
+$489.26 (+48.9%) today · 1.49× · US Dollar
Based on a KURA entry price of $6.05 vs. today's $9.01.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.39 | $867.18 | -13.3% |
| 1 month ago | $10.78 | $835.81 | -16.4% |
| 3 months ago | $8.77 | $1,027.37 | +2.7% |
| 6 months ago | $8.27 | $1,089.48 | +8.9% |
| 1 year ago | $6.05 | $1,489.26 | +48.9% |
| All time (5.0y) ago | $18.95 | $475.46 | -52.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KURA forecast.
Our base-case forecast reaches $18.00 around 2033.
Implied market cap at $18.00: $1.6B
The multi-year forecast shows a bullish trajectory after 2026. The 2027 average price is $12.10 with a 29.9% ROI and a bullish sentiment, followed by 2028 at $15.38 (65.2%), 2029 at $15.63 (67.9%), and 2030 at $16.72 (79.6%). The trend continues into the 2030s with 2031 at $18.92 (103.2%), 2032 at $18.69 (100.8%), 2033 at $21.34 (129.3%), 2034 at $25.79 (177%), and 2035 at $28.57 (206.8%), all with bullish sentiment.
By 2040 the average is $38.14 (309.7%), and by 2050 the average reaches $83.07 with a 792.2% ROI, with a maximum forecast of $153.09. These figures reflect an upside trajectory but remain subject to market and development risks and should be interpreted as estimates, not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $16.72 with a min of $12.42, a max of $24.26 and a ROI of 79.6%; sentiment is BULLISH.
Forecasts indicate bullish sentiment from 2027 onward with rising averages and positive ROIs (e.g., 2027 avg $12.10, ROI 29.9%; 2028 avg $15.38, ROI 65.2%), but these are estimates and not guarantees.
Yes, the maximum forecast by 2050 is $153.09, with an average of $83.07 in 2050. The path to $100 is within the forecast range, but not guaranteed.
Sentiment is NEUTRAL; RSI 14 is 40. The 50-day SMA is $10.20 and the 200-day SMA is $9.66, with support at $8.86 and resistance at $12.12; the 30-day range spans $7.79 to $11.13.
Current price is $9.31 and market cap is $826.49M.
Kura Oncology, Inc. Community Discussion
0Share your Kura Oncology, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.